Release according to Article 40, Section 1 of the WpHG

What happened

Qiagen said the Netherlands Authority for the Financial Markets notified it on October 31, 2026, of a Barclays Plc voting-rights disclosure recorded for an October 28 transaction. The notice lists Barclays-linked holdings and instruments, including ordinary shares, a convertible bond, a swap and a contract for difference.

Confirmed

Global impact / market context

The disclosure identifies Barclays-related exposure to Qiagen shares and contracts linked to its voting rights, but does not establish a change in Qiagen’s operations or finances. Investors can use the filing to understand reported ownership-related positions, not as evidence of a company funding or earnings change.

Analyst inference

The notice mixes direct share holdings with instruments whose share and voting-rights figures are described as potential. That distinction matters because some positions may confer rights only under certain conditions; the excerpt does not provide totals, thresholds crossed, or the complete disclosure.

Analyst inference

What to watch

1. Review the full AFM register notice for the complete instrument breakdown and any reported voting-rights totals; the supplied excerpt ends before all entries are shown. Analyst inference
2. Check whether subsequent disclosures show changes in Barclays Plc’s reported Qiagen positions, which would clarify whether this filing reflects a continuing or altered exposure. Analyst inference
3. The excerpt reports a transaction date of October 28 and notification on October 31, 2026; it does not state that Qiagen issued new shares. Confirmed

Evidence

• Original source link unavailable